The goal of this project is to complete the development of a unique, non-toxic thin film technology to be used as a skin barrier that is worn underneath surgical and examination gloves. The efficacy of gloves has become an important issue, especially for healthcare workers where exposure to blood or other body fluids is frequent. This technology has been developed to reduce transmission of bacteria and bloodborne pathogens. Glove punctures are frequent, and the potential for pathogen transmission is increasingly significant. Additionally, with the heightened awareness of bloodborne pathogens, the use of exam gloves has increased. The proposed technology can provide skin protection from the detrimental effects of chronic glove wearing and hand washing. The following Phase II studies have been designed to complete the development of this novel underglove technology: 1) implementation of Good Manufacturing Practices (GMP) and establishment of packaging, 2) evaluation of coating formulations for effects on skin physiology, and 3) demonstration of the safety of coatings in human safety studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AI045278-02A1
Application #
6694006
Study Section
Special Emphasis Panel (ZRG1-SSS-W (10))
Program Officer
Korpela, Jukka K
Project Start
1999-09-30
Project End
2005-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
2
Fiscal Year
2003
Total Cost
$350,642
Indirect Cost
Name
Biomedical Development Corporation
Department
Type
DUNS #
145377966
City
San Antonio
State
TX
Country
United States
Zip Code